The Patterns of Non-vitamin K Antagonist Oral Anticoagulants (NOACs) Use in Patients with Atrial Fibrillation in Seven Balkan Countries: a Report from the BALKAN-AF Survey
Tatjana S Potpara,Elina Trendafilova,Gheorghe-Andrei Dan,Artan Goda,Zumreta Kusljugic,Sime Manola,Ljilja Music,Viktor Gjini,Belma Pojskic,Mircea Ioakim Popescu,Catalina Arsenescu Georgescu,Elena S Dimitrova,Delyana Kamenova,Uliks Ekmeciu,Denis Mrsic,Ana Nenezic,Sandro Brusich,Srdjan Milanov,Ivan Zeljkovic,Gregory Y H Lip,BALKAN-AF Investigators,Rodica Musetescu,Mircea Ioachim Popescu,Elisabeta Badila,Sorina Pop,Raluca Popescu,Simina Neamtu,Floriana Oancea,Anca Rodica Dan,Tatjana Potpara,Marija Polovina,Gorana Mitic,Marko Milanov,Jelena Savic,Snezana Markovic,Ivana Koncarevic,Jelena Gavrilovic,Marija Pavlovic,Dijana Djikic,Marijana Petrovic,Stefan Simovic,Semir Malic,Jusuf Hodzic,Milovan Stojanovic,Sanja Gnip,Milan Zlatar,Dragan Matic,Snezana Lazic,Tijana Acimovic,Pavica Radovic,Vladan Peric,Sanja Markovic,Snezana Kovacevic,Aleksandra Arandjelovic,Milika Asanin,Milan M Nedeljkovic,Marija Zdravkovic,Marina Deljanin Ilic,Elena Dimitrova,Stanislav Petranov,Penka Kamenova,Svetoslava Elefterova,Valentin Shterev,Maria Zekova,Stela Diukiandzhieva,Evgenii Goshev,Boiko Dimitrov,Tihomir Sotirov,Valentina Simeonova,Anna Velichkova,Dimitrina Drianovska,Liliya Ivanova Vasileva Boiadzhieva,Darina Buchukova,Vilma Paparisto,Uliks Ekmekciu,Hortensia Gjergo,Alma Mijo,Ervina Shirka,Ina Refatllari,Daniela Loncar,Alma Sijamija,Amira Bijedic,Irma Bijedic,Indira Karamujic,Sanela Halilovic,Hazim Tulumovic,Sekib Sokolovic,Ante Anic,Nikola Pavlovic,Vjekoslav Radeljic,Melita Jeric,Petar Pekic,Kresimir Milas,Nebojsa Bulatovic,Dijana Asanovic
DOI: https://doi.org/10.1007/s12325-017-0589-5
Abstract:Introduction: Data on management of atrial fibrillation (AF) in the Balkan Region are scarce. To capture the patterns in AF management in contemporary clinical practice in the Balkan countries a prospective survey was conducted between December 2014 and February 2015, and we report results pertinent to the use of non-vitamin K antagonist oral anticoagulants (NOACs). Methods: A 14-week prospective, multicenter survey of consecutive AF patients seen by cardiologists or internal medicine specialists was conducted in Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Montenegro, Romania, and Serbia (a total of about 50 million inhabitants). Results: Of 2712 enrolled patients, 2663 (98.2%) had complete data relevant to oral anticoagulant (OAC) use (mean age 69.1 ± 10.9 years, female 44.6%). Overall, OAC was used in 1960 patients (73.6%) of whom 338 (17.2%) received NOACs. Malignancy [odds ratio (OR), 95% confidence interval (CI) 2.06, 1.20-3.56], rhythm control (OR 1.64, 1.25-2.16), and treatment by cardiologists were independent predictors of NOAC use (OR 2.32, 1.51-3.54) [all p < 0.01)], whilst heart failure and valvular disease were negatively associated with NOAC use (both p < 0.01). Individual stroke and bleeding risk were not significantly associated with NOAC use on multivariate analysis. Conclusions: NOACs are increasingly used in AF patients in the Balkan Region, but NOAC use is predominantly guided by factors other than evidence-based decision-making (e.g., drug availability on the market or reimbursement policy). Efforts are needed to establish an evidence-based approach to OAC selection and to facilitate the optimal use of OAC, thus improving the outcomes in AF patients in this large region.